|
Core Support for Cancer Center
|
3P30CA013330-44S1
|
$199,871
|
$1,999
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Core Support for Cancer Center
|
3P30CA013330-44S2
|
$199,989
|
$2,000
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Core Support for Cancer Center
|
3P30CA013330-44S3
|
$500,000
|
$5,000
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Core Support for Cancer Center
|
5P30CA013330-44
|
$3,746,138
|
$37,461
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Inhibition of Senescence to Increase Cancer Cell Death: A New Paradigm
|
5R01CA077263-17
|
$413,086
|
$136,318
|
MCDAID, HAYLEY
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
The Role of SRC-1 in Breast Cancer
|
4R01CA112403-10
|
$269,732
|
$67,433
|
XU, JIANMING
|
BAYLOR COLLEGE OF MEDICINE
|
|
Role of Axl in docetaxel resistance in prostate cancer
|
5R21CA187843-02
|
$160,515
|
$160,515
|
LIBERMANN, TOWIA
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-26S1
|
$20,833
|
$417
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-26S2
|
$60,000
|
$1,200
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-26S3
|
$118,406
|
$2,368
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-26S4
|
$200,000
|
$4,000
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
4P30CA043703-26
|
$4,895,515
|
$97,910
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Targeting BET proteins in Triple Negative Breast Cancer
|
1R01CA206505-01
|
$373,968
|
$186,984
|
KERI, RUTH
|
CASE WESTERN RESERVE UNIVERSITY
|
|
c-Abl-mediated Suppression of Breast Cancer Development and Metastasis
|
4R01CA177069-04
|
$328,265
|
$82,066
|
SCHIEMANN, WILLIAM
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Nanoparticle-mediated treatment for bone metastasis
|
1R01CA206189-01
|
$312,562
|
$312,562
|
LABHASETWAR, VINOD
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
Total Synthesis and Biosynthesis of Bioactive Substances
|
5R01CA070375-20
|
$256,101
|
$128,051
|
WILLIAMS, ROBERT
|
COLORADO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA006516-51S1
|
$122,500
|
$1,225
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-51S2
|
$37,500
|
$375
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-51S3
|
$125,000
|
$1,250
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-51S4
|
$200,000
|
$2,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-51S5
|
$60,000
|
$600
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-51S6
|
$199,953
|
$2,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-51S7
|
$500,000
|
$5,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-51S8
|
$750,000
|
$7,500
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
4P30CA006516-51
|
$11,151,311
|
$111,513
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
(PQ9) The role of Bclw (bcl2l2) in preventing chemotherapy induced neuropathy
|
1R01CA205255-01
|
$577,463
|
$577,463
|
SEGAL, ROSALIND
|
DANA-FARBER CANCER INST
|
|
The mechanism of DNA damage and chromothripsis from chromosome segregation errors
|
1K08CA208008-01
|
$177,120
|
$177,120
|
SPEKTOR, ALEXANDER
|
DANA-FARBER CANCER INST
|
|
Analysis of Blood Borne Markers in Hormone Sensitive Metastatic Prostate Cancer
|
1R01CA208254-01
|
$556,793
|
$167,038
|
SWEENEY, CHRISTOPHER
|
DANA-FARBER CANCER INST
|
|
SPORE: Dana-Farber/Harvard Cancer Center SPORE in Breast Cancer
|
4P50CA168504-04
|
$2,161,168
|
$64,835
|
WINER, ERIC
|
DANA-FARBER CANCER INST
|
|
Chlorotoxin as a Targeting Agent for Cancer Therapies
|
5R01CA135491-08
|
$396,000
|
$198,000
|
OLSON, JAMES
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Moffitt Cancer Center Support Grant
|
3P30CA076292-18S1
|
$126,375
|
$1,264
|
SELLERS, THOMAS
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Moffitt Cancer Center Support Grant
|
3P30CA076292-18S2
|
$241,075
|
$2,411
|
SELLERS, THOMAS
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Moffitt Cancer Center Support Grant
|
3P30CA076292-18S3
|
$125,000
|
$1,250
|
SELLERS, THOMAS
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Moffitt Cancer Center Support Grant
|
3P30CA076292-18S4
|
$60,000
|
$600
|
SELLERS, THOMAS
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Moffitt Cancer Center Support Grant
|
3P30CA076292-18S5
|
$1,000,000
|
$10,000
|
SELLERS, THOMAS
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Moffitt Cancer Center Support Grant
|
4P30CA076292-18
|
$2,930,104
|
$29,301
|
SELLERS, THOMAS
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
A Novel Oncogenic Role for Cdc20 Implications in Adult T Cell Leukemia Treatment
|
4R00CA183914-03
|
$248,999
|
$248,999
|
WAN, LIXIN
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Indiana University Melvin and Bren Simon Cancer Center Support Grant
|
3P30CA082709-17S1
|
$106,993
|
$1,070
|
LOEHRER, PATRICK
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Indiana University Melvin and Bren Simon Cancer Center Support Grant
|
3P30CA082709-17S2
|
$174,513
|
$1,745
|
LOEHRER, PATRICK
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Indiana University Melvin and Bren Simon Cancer Center Support Grant
|
3P30CA082709-17S3
|
$152,900
|
$1,529
|
LOEHRER, PATRICK
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Indiana University Melvin and Bren Simon Cancer Center Support Grant
|
3P30CA082709-17S4
|
$143,694
|
$1,437
|
LOEHRER, PATRICK
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Indiana University Melvin and Bren Simon Cancer Center Support Grant
|
3P30CA082709-17S5
|
$249,947
|
$2,499
|
LOEHRER, PATRICK
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Indiana University Melvin and Bren Simon Cancer Center Support Grant
|
3P30CA082709-17S6
|
$200,320
|
$2,003
|
LOEHRER, PATRICK
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Indiana University Melvin and Bren Simon Cancer Center Support Grant
|
5P30CA082709-17
|
$2,184,000
|
$21,840
|
LOEHRER, PATRICK
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
NOS1AP as a novel target for treating pathological pain
|
1R01CA200417-01A1
|
$295,021
|
$97,357
|
HOHMANN, ANDREA
|
INDIANA UNIVERSITY BLOOMINGTON
|
|
Camptothecin Transformative Nanotubes as Effective Drug Carriers
|
5R21CA191740-02
|
$170,845
|
$85,423
|
CUI, HONGGANG
|
JOHNS HOPKINS UNIVERSITY
|
|
Single Cell In Vivo Imaging Technology to Analyze Taxane Nano Formulations in Breast Cancer
|
1K99CA207744-01
|
$179,280
|
$179,280
|
MILLER, MILES
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Mayo Clinic Ovarian Cancer SPORE
|
5P50CA136393-07
|
$2,162,000
|
$108,100
|
KAUFMANN, SCOTT
|
MAYO CLINIC ROCHESTER
|
|
Enhancing Therapy of Primary and Recurrent Tumors With Systemic Oncolytic Virus
|
5R01CA175386-03
|
$263,940
|
$131,970
|
VILE, RICHARD
|
MAYO CLINIC ROCHESTER
|
|
Novel Bone-Targeting Combination Therapy for Osteosarcoma
|
1R43CA203166-01
|
$301,877
|
$301,877
|
ZINNEN, SHAWN
|
MBC RESEARCH, INC.
|
Total relevant funding to Taxol for this search: $16,913,742
|